Since the release of IFN‐γ and IL2 from Th1 cells can promote differentiation of naïve CD8+ T cells into cytotoxic T cells, Th1 cells are considered the most prominent subtype for anti‐tumour immunity (Tay et al, 2020). The gene discussed is IFNG; the disease is neoplasm.